Table 6b.
Prevalence ratios by level of GFR, excluding medication use
| Medical Condition | n | CKiD GFR Categories,a ml/min per 1.73 m2 |
|||
|---|---|---|---|---|---|
| ≥50 (reference) | ≥40 to <50, Estimate (95% CI) | ≥30 to <40, Estimate (95% CI) | <30, Estimate (95% CI) | ||
| Elevated potassium (>5.2 mEq/L) | 566 | 1 | 2.09 (0.91, 4.83) | 2.21 (0.97, 5.01) | 4.69 (2.23, 9.86) |
| Acidotic (CO2 <21 mEq/L)b | 415 | 1 | 1.80 (1.12, 2.89) | 2.25 (1.41, 3.61) | 2.73 (1.72, 4.33) |
| Elevated phosphatec | 455 | 1 | 1.57 (0.64, 3.84) | 2.02 (0.85, 4.81) | 5.68 (2.65, 12.14) |
| Growth failure (height <3rd percentile) | 502 | 1 | 1.81 (0.93, 3.53) | 2.27 (1.20, 4.33) | 2.62 (1.36, 5.05) |
| Anemia (excluding ESA use only) | 495 | 1 | 1.68 (1.07, 2.66) | 2.66 (1.76, 4.00) | 3.85 (2.59, 5.72) |
| Anemia (excluding ESA and iron use) | 384 | 1 | 1.83 (1.05, 3.17) | 2.79 (1.67, 4.67) | 4.10 (2.51, 6.70) |
| Hypertension (BP ≥95th percentile for age and gender or self-reported hypertension and on a antihypertensive medication) | 565 | 1 | 1.00 (0.80, 1.26) | 1.04 (0.83, 1.29) | 1.36 (1.12, 1.65) |
| High cholesterold | 489 | 1 | 1.47 (0.96, 2.26) | 1.77 (1.18, 2.64) | 1.55 (0.98, 2.45) |
CKiD, Chronic Kidney Disease in Children study; CI, confidence interval; ESA, erythropoiesis stimulating agent.
a
Prevalence ratio estimation determined using Poisson regression with robust error variance.
b
On the basis of locally measured values of CO2.
c
On the basis of the phosphate norms reported in reference 29.
d
On the basis data from reference 28.